CST3 and diabetes mellitus: A previous study of 778 adults (aged 20 or older) investigating Cystatin C compared to creatinine based on eGFR showed that Cystatin C was found to reduce kidney function earlier, especially in patients with diabetes, indicating it could be used as an earlier marker of kidney damage [24].